BusinessPROVECTUS BIOPHARMACEUTICALS PROVIDES UPDATE ON GI CANCER PROGRAM FOR INVESTIGATIONAL DRUG PV-10By Nasdaq OMXFeb 22, 2018, 12:01 PM UTC